In-silico Designing of Novel Camptothecin Analogues as Potent Inhibitors of Topoisomerase I: A Molecular Docking, QSAR, and ADME-T Study

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|9|859-868

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.9, 2016-10, pp. : 859-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D-QSAR, Molecular Docking and Molecular Dynamics Studies of 2,4- Diarylaminopyrimidine Analogues (DAAP Analogues) as Potent ALK Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 3, 2017-01 ,pp. : 270-286

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Docking, In-Silico ADMET Study and Development of 1,6- Dihydropyrimidine Derivative as Protein Tyrosine Phosphatase Inhibitor: An Approach to Design and Develop Antidiabetic Agents

By  

Current Computer - Aided Drug Design, Vol. 14, Iss. 4, 2018-12 ,pp. : 349-362

Bentham Science Publishers

Access to resources Recommend Favorite

Novel camptothecin derivatives as topoisomerase I inhibitors

By Basili Serena   Moro Stefano  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 555-574

Informa Healthcare

Access to resources Recommend Favorite

Molecular Docking and In Silico ADMET Study Reveals Flavonoids as a Potential Inhibitor of Aromatase

By  

Letters in Drug Design & Discovery, Vol. 14, Iss. 11, 2017-10 ,pp. : 1267-1276

Bentham Science Publishers

Access to resources Recommend Favorite

Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors

By  

Current Computer - Aided Drug Design, Vol. 11, Iss. 3, 2015-09 ,pp. : 245-257

Bentham Science Publishers

Access to resources Recommend Favorite